[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112012014678A2 - "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento" - Google Patents

"uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento"

Info

Publication number
BR112012014678A2
BR112012014678A2 BR112012014678A BR112012014678A BR112012014678A2 BR 112012014678 A2 BR112012014678 A2 BR 112012014678A2 BR 112012014678 A BR112012014678 A BR 112012014678A BR 112012014678 A BR112012014678 A BR 112012014678A BR 112012014678 A2 BR112012014678 A2 BR 112012014678A2
Authority
BR
Brazil
Prior art keywords
rosacea
diagnosis
monitoring method
dna mrna
mrna
Prior art date
Application number
BR112012014678A
Other languages
English (en)
Inventor
Johannes Voegel
Jérôme Aubert
Martin Steinhoff
Michel Rivier
Original Assignee
Galderma Res & Dev
Uni Munster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Uni Munster filed Critical Galderma Res & Dev
Publication of BR112012014678A2 publication Critical patent/BR112012014678A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR112012014678A 2009-12-17 2010-12-16 "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento" BR112012014678A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28211309P 2009-12-17 2009-12-17
PCT/EP2010/069896 WO2011073321A1 (en) 2009-12-17 2010-12-16 Markers and method for the diagnosis of rosacea

Publications (1)

Publication Number Publication Date
BR112012014678A2 true BR112012014678A2 (pt) 2016-04-05

Family

ID=43417037

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012014678A BR112012014678A2 (pt) 2009-12-17 2010-12-16 "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento"

Country Status (12)

Country Link
US (1) US20130017969A1 (pt)
EP (1) EP2513328A1 (pt)
JP (1) JP2013514070A (pt)
KR (1) KR20120115321A (pt)
CN (1) CN102762742A (pt)
AU (1) AU2010332876A1 (pt)
BR (1) BR112012014678A2 (pt)
CA (1) CA2783693A1 (pt)
IN (1) IN2012DN06279A (pt)
MX (1) MX2012006623A (pt)
RU (1) RU2012130069A (pt)
WO (1) WO2011073321A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2723893B1 (en) * 2011-06-27 2018-11-21 Galderma Research & Development New th-17 differentiation markers for rosacea and uses thereof
EP2723892A2 (en) * 2011-06-27 2014-04-30 Galderma Research & Development New th-17 differentiation markers for rosacea and uses thereof
WO2013060865A1 (en) * 2011-10-28 2013-05-02 Galderma Research & Development New leukocyte infiltrate markers for rosacea and uses thereof
CA2857751A1 (en) * 2011-12-16 2013-06-20 Galderma Research & Development Method for the diagnosis of rosacea
US9860241B2 (en) * 2014-04-15 2018-01-02 Level 3 Communications, Llc Device registration, authentication, and authorization system and method
KR101712747B1 (ko) 2015-11-06 2017-03-07 가톨릭대학교 산학협력단 유파틸린을 유효성분으로 포함하는 피부질환 예방 또는 치료용 조성물
CN106119348B (zh) * 2016-06-27 2018-02-23 中南大学湘雅医院 一种以非编码lnc‑CXCL1及编码基因cxcl1组合为检测或诊断筛查标志物的重症肌无力检测试剂盒及应用
KR102216941B1 (ko) * 2020-08-12 2021-02-18 주식회사 큐티스의생명연구센터 마이크로니들 패치를 포함하는 최소 침습적 홍조성 민감피부 평가 키트 및 홍조성 민감피부 평가를 위한 바이오마커
JP2022554046A (ja) * 2020-08-10 2022-12-28 カティス バイオメディカル リサーチ センター マイクロニードルパッチを含む最小侵襲的皮膚状態の診断キット
CN113462770B (zh) * 2021-08-25 2023-03-31 中国医科大学附属第一医院 趋化因子作为玫瑰痤疮诊断的分子标志物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118141A1 (en) * 2005-05-04 2009-05-07 The Regents Of The University Of California Methods of oligosaccharide profiling for the detection of ocular rosacea
WO2007077257A2 (en) * 2006-01-05 2007-07-12 Galderma Research & Development Acne lesions biomarkers and modulators thereof
US20090318534A1 (en) * 2006-09-27 2009-12-24 The Regents Of The University Of California Methods and compositions for the treatment of skin diseases and disorders
WO2009053493A1 (en) * 2007-10-26 2009-04-30 Galderma Research & Development Non-invasive method to perform skin inflammatory disease pharmaco-genomic studies and diagnosis method thereof
FR2923610B1 (fr) 2007-11-14 2009-11-27 Galderma Res & Dev Methode non-invasive de recueil de donnees biologiques pour l'etablissement d'un diagnostic d'une pathologie cutanee.

Also Published As

Publication number Publication date
US20130017969A1 (en) 2013-01-17
EP2513328A1 (en) 2012-10-24
KR20120115321A (ko) 2012-10-17
AU2010332876A1 (en) 2012-07-12
IN2012DN06279A (pt) 2015-09-25
JP2013514070A (ja) 2013-04-25
MX2012006623A (es) 2012-11-30
CN102762742A (zh) 2012-10-31
CA2783693A1 (en) 2011-06-23
RU2012130069A (ru) 2014-01-27
WO2011073321A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
BR112012014678A2 (pt) "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento"
BRPI1009004A2 (pt) método para integrar diagnóstico e tratamento para tecidos internos, e, sistema para integrar diagnóstico e tratamento para tecidos internos
BRPI0910608A2 (pt) métodos e sistemas para avaliar resultados clínicos
BRPI1016147A2 (pt) sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino
BRPI0917250A2 (pt) sistema para detecção de tecido em um paciente, sistema para detectar característica de tecido em um paciente
BRPI1013625A2 (pt) sistema, e método para determinar saúde de equipamento
BRPI0907279A2 (pt) sistema de monitoramento fetal e método para o monitoramento fetal.
BRPI0914310A2 (pt) sistemas, aparelhos, e métodos para prover eletroterapia não transcraniana
BR112012014418A2 (pt) metodo para monitirar escovação dentaria e sistema
BR112013020352A2 (pt) composto, composição farmacêutica, uso de um composto e método para tratar doença ou condição mediana por rorgamat num indivíduo
BRPI0806559A2 (pt) Sistema e método de monitor para semeadeira
BRPI1009420A2 (pt) axmi-001, axmi-002, axmi-030, e axmi-045; genes de toxina e métodos para seu uso
BRPI1010798A2 (pt) fechamento, aparelho de retenção, e método de uso do mesmo
BR112013000745A2 (pt) "método para diagnosticar ou detectar câncer colorretal em um individuo, método de tratamento e método para monitorar a eficacia de tratamento de câncer colorretal em um indivíduo"
BRPI0815677A2 (pt) Catalisador de hidrogenação aromático e método de produção e uso do referido catalisador
BRPI1016158A2 (pt) "sistema e método para monitorar um desempenho atlético, e, sistema e método de monitoramento do desempenho atlético."
BRPI1009381A2 (pt) compostos, composição farmacêutica, método para tratar doença ou condição associada com função de trap1 em sujeito em necessidade do mesmo e uso de compostos e composição farmacêutica
BRPI0905851A2 (pt) Métodos, sistemas, e dispositivos para realizar procedimentos eletrocirúrgicos
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0912426A2 (pt) método executado por computador, computador, e sistema para uso com poço
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BR112012005568A2 (pt) aparelho e métodos para medir processos biológicos
BRPI1007779A2 (pt) perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina
BRPI0924215A2 (pt) método e sistema para execução de medição
BR112012016882A2 (pt) "monólitos de polímero poroso, processos para preparação e uso dos mesmos"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]